Log in
Sign up
Deinove

Deinove

Deinove is a synthetic biology company making antibiotics and bioactives founded in 2006 by Philippe Pouletty.

OverviewStructured DataIssuesContributorsActivity
Contents

Deinove develops antibiotics and bio-based ingredients for cosmetics and nutrition. Deinove researches and develops microbiological technologies for the production of organic acids, antibiotics, ethanol and biofuels.

Deinove owns a large bacterial collection including more than 6000 rare strains collected in different biotopes such as hot springs, volcanos, lagoons, beaches, caves and from various substrates such as wood, water, plant and sand. The company has developed and patented methods for selection and culture or rare bacteria. Deinove’s cell biology lab has characterized their cosmetic activities, such as anti-oxidant, anti-inflammatory and cell regeneration properties.

To improve the production of antibiotic compounds and to achieve optimal performances, the company uses genetic engineering. This involves a custom-made computer-aided design software developed by Deinove and Cad4Bio. The program performs in silico genetic engineering design and operates a robot to perform large-scale DNA cloning and strain construction.

Products
Antibiotics

A phase II clinical trial is planned for Deinove’s antibiotic candidate that targets severe gastrointestinal infections caused by Clostridioides difficile. The candidate was also studied by the United States Army Medical Research Institute of Infectious Diseases for treatment against two biothreat agents: Bacillus anthracis which triggers anthrax and Bacillus anthracis which triggers tularemia or rabbit fever.

Bioactives

Phyt-N-Resist was launched in 2018 and it is a colorless carotenoid produced by fermentation of natural sugars by the extremophilic bacterium Deinococcus geothermalis. The product is claimed to fight the effects of aging skin by reducing oxidative stress and accelerating skin regeneration. A second bio-based carotenoid is being developed by Deinove for the cosmetics market. The product targets a dermocosmetic indication that is on the rise.

HEBELYS is an anti-age, anti-wrinkle and moisturizing product produced by fermentation of Sphingomonas bacteria.

Partnerships

Deinove collaborates with two other companies with bacterial strain collections, Naicons and bioMérieux.

Deinove is collaborating with Dow for the development of a cosmetic ingredient derived from bacterial extracts. Deinove plans to develop and optimize a dedicated production process for an extract selected by Dow from their bacterial bank. Deinove collaborates with Greentech for marketing of their skin care product HEBELYS

Deinove is collaborating with Avril in a program aimed at developing a new range of ingredients for animal feed. The ingredients are produced by bacterial fermentation. The product will be marketed as a raw material for animal feed.

Timeline

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

deinove.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Bioplastic
Bioplastic
Biomedical engineering
Biomedical engineering
Technology
Technology
Synthetic biology
Synthetic biology
Biology
Biology
Biotechnology
Biotechnology
...
Location
France
France
Grabels
Grabels
Occitanie
Occitanie
B2X
B2B
B2B
CEO
‌
Emmanuel Petiot
Founder
Philippe Pouletty
Philippe Pouletty
Pitchbook URL
pitchbook.com/profiles.../56698-75
Date Incorporated
2006
Number of Employees (Ranges)
51 – 200
Full Address
1682 Rue de la Valsière, 34790 Grabels, France
Investors
Bpifrance (public entity)
Bpifrance (public entity)
Truffle Capital
Truffle Capital
TVM Capital
TVM Capital
Founded Date
2006
Phone Number
+33448190100
Total Funding Amount (USD)
5,401,450
Latest Funding Round Date
March 2020
Competitors
Lysogene
Lysogene
Fusion Genomics
Fusion Genomics
Nanobiotix
Nanobiotix
Avellino Labs
Avellino Labs
Genebox
Genebox
Cradle Genomics
Cradle Genomics
Global Bioenergies
Global Bioenergies
Business Model
Commerce
Stock Symbol
ALDEI
Exchange
Euronext
Euronext
Glassdoor ID
1129045
Latest Funding Type
Private equity
Private equity
Patents Assigned (Count)
10

Other attributes

Company Operating Status
Active
Country
France
France

Find more companies like Deinove

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.